Marker Therapeutics

MRKR

Market cap $21.2M

1.28 USD

+0.01

0.79%

At close Updated Dec 17, 4:00 PM EST

Pre-market

After hours

1.31

+0.03

2.34%

1 day

0.79%

5 days

-11.72%

1 month

34.06%

3 months

34.69%

6 months

-14.67%

Year to date

-59.75%

1 year

-73.66%

5 years

-91.95%

10 years

-97.66%

About: Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Employees: 5

Healthcare Biotechnology